Yang C - Search Results

1

Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.

Tao K, Guo S, Chen R, Yang C, Jian L, Yu H, Liu S. Tao K, et al. Among authors: yang c. Mol Diagn Ther. 2019 Feb;23(1):127-138. doi: 10.1007/s40291-019-00384-3. Mol Diagn Ther. 2019. PMID: 30694446

2

[Over-expression of human S-phase kinase-associated protein 2 (Skp2) promotes proliferation of MCF-7 breast cancer cells and increases the number of S phase cells].

Yang C, Nan K, Qin S. Yang C, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Oct;31(10):1306-10. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015. PMID: 26429528 Chinese.

3

Estrogen receptor α (ERα) status evaluation using RNAscope in situ hybridization: a reliable and complementary method for IHC in breast cancer tissues.

Yu X, Guo S, Song W, Xiang T, Yang C, Tao K, Zhou L, Cao Y, Liu S. Yu X, et al. Among authors: yang c. Hum Pathol. 2017 Mar;61:121-129. doi: 10.1016/j.humpath.2016.12.005. Epub 2016 Dec 16. Hum Pathol. 2017. PMID: 27993577

4

Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients.

Chen R, Ye Y, Yang C, Peng Y, Zong B, Qu F, Tang Z, Wang Y, Su X, Li H, Yang G, Liu S. Chen R, et al. Among authors: yang c, yang g. Breast Cancer Res Treat. 2018 Jul;170(1):35-43. doi: 10.1007/s10549-018-4730-1. Epub 2018 Feb 26. Breast Cancer Res Treat. 2018. PMID: 29480449 Free PMC article.

5

Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.

Yu H, Yang C, Jian L, Guo S, Chen R, Li K, Qu F, Tao K, Fu Y, Luo F, Liu S. Yu H, et al. Among authors: yang c. Oncol Rep. 2019 Aug;42(2):826-838. doi: 10.3892/or.2019.7189. Epub 2019 Jun 6. Oncol Rep. 2019. PMID: 31173262

6

CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis.

Yang C, Yu H, Chen R, Tao K, Jian L, Peng M, Li X, Liu M, Liu S. Yang C, et al. Int J Oncol. 2019 Sep;55(3):684-696. doi: 10.3892/ijo.2019.4840. Epub 2019 Jul 15. Int J Oncol. 2019. PMID: 31322183 Free PMC article.

7

Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer.

Chen R, Guo S, Yang C, Sun L, Zong B, Li K, Liu L, Tu G, Liu M, Liu S. Chen R, et al. Among authors: yang c. Int J Oncol. 2020 Apr;56(4):932-944. doi: 10.3892/ijo.2020.4987. Epub 2020 Feb 14. Int J Oncol. 2020. PMID: 32319562 Free PMC article.

8

AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner.

Jian L, Xie J, Guo S, Yu H, Chen R, Tao K, Yang C, Li K, Liu S. Jian L, et al. Among authors: yang c. Oncol Lett. 2020 Aug;20(2):1441-1451. doi: 10.3892/ol.2020.11683. Epub 2020 May 28. Oncol Lett. 2020. PMID: 32724387 Free PMC article.

9

Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.

Jiang L, Liang X, Liu M, Wang W, Ma J, Guo Q, Han L, Yang C, Nan K. Jiang L, et al. Among authors: yang c. Oncol Rep. 2014 Nov;32(5):1931-8. doi: 10.3892/or.2014.3432. Epub 2014 Aug 21. Oncol Rep. 2014. PMID: 25175672

10

[High expression of cyclin D1 is correlated with the expression of estrogen receptor and good prognosis in breast cancer].

Yang C, Nan K, Zhang Y, Chen Y, Qin S. Yang C, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Jan;32(1):84-7. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016. PMID: 26728382 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,534 results

Search Page

Filters